You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Which medications interact with vascepa?



Vascepa (icosapent ethyl) is a prescription medication used to lower high triglyceride levels in adults. It is important to know which medications can interact with Vascepa to avoid any potential adverse effects.

According to Drugs.com [3], there are 95 medications that have a moderate interaction with Vascepa. Some of these medications include aspirin, clopidogrel, and warfarin. These medications can increase the risk of bleeding when taken with Vascepa. It is important to inform your healthcare provider if you are taking any of these medications before starting Vascepa.

There are also 5 medications that have a minor interaction with Vascepa, as listed on MedBroadcast [2]. These include atorvastatin, fenofibrate, and simvastatin. These medications can increase the risk of muscle problems when taken with Vascepa. Your healthcare provider should monitor you closely if you are taking any of these medications with Vascepa.

DrugPatentWatch [1] does not provide information on medication interactions with Vascepa.

It is important to always inform your healthcare provider of all medications, supplements, and vitamins you are taking before starting Vascepa or any other new medication. This will help ensure your safety and prevent any potential interactions.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.medbroadcast.com/drug/getdrug/vascepa
[3] https://www.drugs.com/drug-interactions/icosapent,vascepa.html



Follow-up:   How does vascepa interact with statins? Is vascepa safe to take with blood thinners? Are there any dietary restrictions while taking vascepa?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.